DL

Doosari Lovelyi

Director Director DIN 00473009
DIN 00473009 First appointment Apr 2002 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2002
Shareholding value Locked Premium profile

About Doosari Lovelyi

Data last updated:

Doosari Lovelyi has 24 years in corporate governance. Formerly with 1 company, such as Chennat Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

DIN 00473009
Primary Designation Director
First Appointment 01 Apr 2002
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Chennat Pharmaceuticals Pvt Ltd U24231KL1993PTC007225
Director01 Apr 20021993Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chennat Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Doosari Lovelyi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Doosari Lovelyi

Doosari Lovelyi has 24 years in corporate governance. Formerly with 1 company, such as Chennat Pharmaceuticals Pvt Ltd. Engaged in General Business. Contributes to corporate operations.

Doosari Lovelyi is associated with 0 companies as a director.

Doosari Lovelyi has expertise in General Business.

Doosari Lovelyi has 24 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available